Charles Theuer, President and CEO at Tracon Pharmaceuticals, Inc. (TCON), bought 5,000 shares at $1.52 ($8K) on 2023-03-01, disclosed to the SEC on 2023-03-02.
Open-market purchase of $8k TCON by President and CEO. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.52 | 200 | $304 | 4.0% |
| 2 | $1.52 | 4,800 | $7K | 96.0% |
| Total | $1.52 avg | 5,000 | $8K | 100% |
| Filing → |
| TCON | BUY | 2022-12-15 | $30K | — | Filing → |
| TCON | BUY | 2022-11-22 | $20K | — | Filing → |
| TCON | BUY | 2022-11-04 | $14K | — | Filing → |